Allergan Plc

Dividend yield
Dividend has grown by 25.53% in last three years.
1.53 %
$2.96 anually
P/E ratio
Payout ratio
Proportion of net income paid out as dividends to shareholders
Company profitability (EPS)
past 12 months
CASH payout ratio
Allergan Plc last quarter cash income being paid in the form of dividends.
Last quarter
Become our supporter to unlock all data!
Stock volatility (Beta)
See how volatile AGN stock is compared to other dividend stocks and to its sector
past 12 months
Become our supporter to unlock all data!
Company debt level
How much debt Allergan Plc have in comparison to other dividend stocks
Become our supporter to unlock all data!
Allergan Plc description

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States.

The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

Company profile
Market cap
Mega (63.36B)
Company CEO
Brenton L. Saunders
Price history Allergan Plc
Loading price stock history...
AGN dividends payouts
Similar stocks as Allergan Plc